30 closest matches · ranked by relevance
Cancer
Primary: Interviews — 20 Interviews
Hypertension · Dyslipidemias · Diabetes
Primary: Undertreatment of Hypertension (>=140/90 mmHg), Dyslipidemia (LDL >=160 mg/dL or Triglyceride >=150 mg/dL), and/or Glucose Intolerance (if Prediabetes, Hemoglobin A1c…
Adult Solid Neoplasm · Lymphoma
Primary: Direct Communication About Age-related Concerns: Number of Discussions Related to the Geriatric Assessment That Occur in the Clinic Visit Between the Patient, Oncology…
Breast Cancer · Colorectal Cancer
Primary: Proportion of Complex Cancer Survivors Meeting Quality of Care Guidelines for Chronic Conditions and Follow-up Cancer Surveillance
Infectious Disease · Cancer · Coronavirus Infection
Primary: Percentage of Patients at Each Sample Timepoint With a Positive Detection of Immunoglobulin G (IgG) Specific Antibodies to SARS-CoV-2 (Spike-protein). — 34.9; 38.3…
Survivorship · Cancer · Symptoms and Signs
Primary: Number of Participants Who Logged Data at Least Three Times in the POSTHOC App — 12; 1 Participants
Cancer Metastatic to Brain · Brain Metastases, Adult
Primary: Assess the Need for Adaptations to the CALM Intervention as Measured by the Applicability of the 4 CALM Domains — 3.2; 4.0; 4.0; 3.5 score on a scale
Smoking Cessation
Primary: Number of Participants With Biochemically Verified 7-day Point Prevalence Tobacco Abstinence at 6 Months — 29; 51 Participants
Cancer
Primary: Proportion of Patients Being Receiving Treatment Administration After Diagnosis — 372 Participants
Cancer Prevention
Primary: Composite Cancer Screening Tests up to Date — 3087; 2590; 3866 Participants — p=.025
Cancer · Young Adult · Pain
Primary: Intervention Satisfaction: Satisfaction With Therapy and Therapist Scale-Revised (STTS-R) — 26.71; 27.33; 28.86; 27.75 scores on a scale — p=0.519
Smoking, Cigarette
Primary: Smoking 7-Day Point Prevalence at 12 Weeks — 2; 2; 3 Participants
Hematopoietic and Lymphoid Cell Neoplasm · Malignant Solid Neoplasm
Primary: Sleep Disturbance, Pain, Anxiety, Depression, Fatigue (SPADE) Symptom Scores. — 2.09; 1.98; 1.90; 1.81 score on a scale
Cancer
Primary: Symptom Severity Index- Comparison of Two Groups Created by First Randomization — 26.28; 26.55; 12.02; 11.19 units on a scale — p=.81
Anti-p53 TCR-Gene
Primary: Clinical Tumor Regression — 1 Participants
Lung Cancer · Tobacco Use Disorder · Breast Cancer
Primary: Feasibility of a Smoking Cessation Intervention Among Cancer Patients — 55; 33 Participants
Lymphoma · Digestive System Diseases · Ovarian Diseases
Primary: Number of Participant Deaths — 56 Participants
Adolescent and Young Adult Cancer Patient
Primary: Treatment Acceptability Questionnaire — 6.02 score on a scale
Neoplasms
Primary: Mean Changes From Baseline in Self-esteem Scores on the Rosenberg Self-esteem Scale (RSES) to Two-, Six-, and Eight Weeks Post Baseline — 23.4; 23.5; 23.7; 24.2 score on…
Lung Cancer · Esophageal Cancer
Primary: Patient Reported Outcomes Measurement Information System (PROMIS) Scores. — 43.05; 51.51; 48.64; 50.74 units on a scale — p=<0.05
Active Breast Cancer Treatment
Primary: Between-group Differences in Patient Complete Illness Understanding at 9-months — 42; 38; 21; 17 Participants — p=0.264
Depression
Primary: Mean Difference in Change of Depressive Symptoms Using the Patient-Reported Outcomes Measurement Information System (PROMIS) -Depression Scale in Primary Central Nervous…
Colo-rectal Cancer
Primary: Mean Physical Health of Patient at Enrollment — 77.2; 82.7 score on a scale
Fatigue · Self Efficacy · Quality of Life
Primary: Cancer-related Fatigue Severity Using The Brief Fatigue Inventory. — 0.56; 4.19; 4.93 Scores on a scale
Myelodysplastic Syndrome · Hodgkin's Lymphoma · Non-Hodgkin's Disease
Primary: Percentage of Participants With Grade II-IV Acute Graft Versus Host Disease (GVHD) — 42; 38 percentage of participants
Pain, Chronic · Cancer
Primary: Improvement of Pain. — 3 score on a scale (0-10)
Cancer
Primary: Number of Study Participants Who Have Completed a Palliative Care Visit Within 3 Months of Enrollment — 22; 130 participants
Colon Cancer · Rectal Cancer
Primary: Patient Retention and Engagement With the MyChemoCare Application — 15; 12 Participants
End of Life · Cancer
Primary: Edmonton Symptom Assessment Scale (ESAS) Symptom Screen — 7; 7 total score on a scale
Breast Cancer
Primary: Number of Participants Offered and Screened for Distress — 596; 3 Participants